27 results
DEF 14A
EVOK
Evoke Pharma Inc
8 Apr 14
Definitive proxy
12:00am
as a director of our company.
Board Independence
Our board of directors has determined that all of our directors are independent directors within … . The nominating and corporate governance committee manages risks associated with the independence of the board, corporate disclosure practices
PRE 14A
EVOK
Evoke Pharma Inc
12 Mar 21
Preliminary proxy
8:30am
Independence
Our board of directors has determined that all of our directors are independent directors within the meaning of the applicable Nasdaq Stock … governance committee manages risks associated with the independence of the board, corporate disclosure practices, and potential conflicts of interest. While
8-K
EX-3.2
x7viop90482s 2xg
30 Sep 13
Amendments to Articles of Incorporation or Bylaws
12:00am
424B4
u1obxio
25 Sep 13
Prospectus supplement with pricing info
12:00am
10-K
h27n hnfo6n
25 Mar 14
Annual report
12:00am
8-K
EX-1.1
zxwdpho81 s4x
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm